Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
Randomized Controlled Trial
About this trial
This is an interventional other trial for Randomized Controlled Trial focused on measuring Baduanjin program, body mass index, metabolic parameters, schizophrenia
Eligibility Criteria
Inclusion Criteria:
- People were diagnosed with schizophrenia at the age of 20-65 years.
- People had taken regular antipsychotic medication for more than 10 weeks
- People lacked regular exercise in the past 3 months.
- People consented to receive blood collection and complete a questionnaire.
- People satisfied the modified Adult Treatment Panel III criteria for Asians i.e., three abnormal results for metabolic syndrome or two abnormal results with BMI > 25)
Exclusion Criteria:
- People with organic mental disorders, alcohol dependence, and substance abuse.
- people who are not willing to sign the consent.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control group
Baduanjin program
The control group (CG) received routine care and was required to walk during 6-7 pm.
The entire program continued for 3 months (mid-September to mid-December 2014), and the intervention was performed for 60 min 3 times per week; particular attention was paid to the disease characteristics of the patients with chronic schizophrenia and to preventing excessive fatigue. Every session began with a 20-min warm-up, followed by 20 min of Baduanjin program, and ended with a cool-down session. The participants were instructed, with the assistance of a video, to practice Baduanjin program in a group by two authors who are experienced in the psychiatric nurses and had been trained in this program.